Related Experiment Video
Updated: Mar 31, 2026
05:08
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
17.9K
[Pharmacokinetics Study on Curcumin Hydroxypropyl-β-Cyclodextrin Phospholipid Complex in Rats]
Zhong Yao Cai = Zhongyaocai = Journal of Chinese Medicinal Materials
|October 27, 2015
Summary
The novel curcumin hydroxypropyl-β-cyclodextrin phospholipid complex significantly enhances curcumin absorption in rats compared to other formulations. This improved pharmacokinetic profile suggests greater bioavailability for this advanced curcumin delivery system.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Natural Product Chemistry
Background:
- Curcumin, a potent natural compound, suffers from poor bioavailability.
- Cyclodextrins and phospholipid complexes are known strategies to improve drug solubility and absorption.
- Combining hydroxypropyl-β-cyclodextrin with phospholipid complex may offer synergistic benefits for curcumin delivery.
Purpose of the Study:
- To compare the in vivo pharmacokinetics of different curcumin complex formulations.
- To evaluate the efficacy of hydroxypropyl-β-cyclodextrin phospholipid complex as a carrier for curcumin.
- To determine the impact of formulation on curcumin absorption and bioavailability.
Main Methods:
- Pharmacokinetic study conducted in Sprague-Dawley (SD) rats.
- Oral administration of curcumin formulations and free curcumin at a dose of 50 mg/kg.
- Quantification of blood curcumin concentrations using High-Performance Liquid Chromatography (HPLC).
Main Results:
- The curcumin hydroxypropyl-β-cyclodextrin phospholipid complex exhibited the highest AUC0-∞ (1126.20 ± 323.24 µg/(L·h)).
- This represents a 5.89-fold increase compared to free curcumin (191.08 ± 43.27 µg/(L·h)).
- The complex also showed superior absorption compared to curcumin phospholipid complex and curcumin hydroxypropyl-β-cyclodextrin.
Conclusions:
- Curcumin hydroxypropyl-β-cyclodextrin phospholipid complex demonstrates superior absorption properties.
- This formulation is more effective in enhancing curcumin bioavailability than simpler complexes.
- The combined carrier system offers significant advantages for improving curcumin's therapeutic potential.
Related Concept Videos
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
89
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
89
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
335
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
335
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
283
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
283
01:17Hepatic Drug Excretion: Enterohepatic Cycling
3.3K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.3K
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
308
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
308
01:30Measurement of Bioavailability: Pharmacokinetic Methods
409
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
409